Skip to main content
. 2018 Oct 29;10(11):407. doi: 10.3390/cancers10110407

Figure 5.

Figure 5

Figure 5

(a) Breast cancer (pT1cN0M0G2, HR+, Her2/neu: neg). 4 times TC (taxane and cyclophosphamide). Tamoxifen interrupted because of side effects. Reiinitiation of Tamoxifen. (b) Breast Cancer (pT2pN0M0). 6 times FEC (fluoruracil, epirubicine and cyclophophasmide, Herceptin, Radiatio, Tamoxifen interrupted. Reiinitiation of Tamoxifen. (c) Breast Cancer (pT2pN2apM0G3) Er+ PR+ Her2/neu FISH neg, 3 times FEC, 3 times Docetaxel, Radiatio, Tamoxifen interrupted, then Letrozol.